Seagen and RemeGen Announce Exclusive Worldwide License and Co-Development Agreement for Disitamab Vedotin Read more
INOVIO and Advaccine Receive Regulatory Allowance for Two Heterologous Prime-Boost Clinical Trials in China Using INO-4800, INOVIO’s COVID-19 DNA Vaccine Candidate Read more
Forxiga approved in the EU for the treatment of chronic kidney disease in patients with and without type-2 diabetes Read more
Epizyme and HUTCHMED Announce Strategic Collaboration to Develop and Commercialize TAZVERIK (tazemetostat) in Greater China Read more
FDA approves Nexviazyme (avalglucosidase alfa-ngpt), an important new treatment option for late-onset Pompe disease Read more
Kite and Appia Bio Announce Collaboration to Research and Develop Allogeneic Cell Therapies for Cancer Read more
10 key reasons to join SMi’s 2nd Annual Next Generation Pharmaceutical Cleanroom Conference Read more
Amring Pharmaceuticals Inc. Announces the Approval and Launch of Generic Isoproterenol Hydrochloride Injection USP Read more